<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-140478</identifier>
<setSpec>0213-9111</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prevalence of Chagas disease in the Bolivian population of Majorca (Spain)</dc:title>
<dc:description xml:lang="en">Objective: To establish the prevalence of Trypanosoma cruzi infection in Bolivian (Spain) participants. Methods: A cross sectional study was carried out in Majorca. Bolivian residents older than 18 years assigned to the family physicians of two primary care centers were randomly selected from the health card population database. Participants were invited to attend a serology test and an interview. T. cruzi infection was confirmed after two positive ELISA tests. If the result was positive or dubious, the serological test was sent to the National Microbiology Center for confirmation. Results: A total of 251 participants were included (response rate 36.3%). The overall seroprevalence of Chagas infection was 19.1% (95% CI: 14.06-24.19). Seroprevalence was higher in participants from highly endemic provinces, those from rural areas, those who had lived in mud houses, and in those whose mother or a family member had contracted this infection. Conclusion: This study demonstrates a high prevalence of T. cruzi in Bolivian residents, which was strongly associated with established risk factors (AU)</dc:description>
<dc:creator>Rodríguez-Ramírez, Ginna</dc:creator>
<dc:creator>Favila Escobio, Pedro</dc:creator>
<dc:creator>Ribas, Joana</dc:creator>
<dc:creator>Vicens-Ferrer, Jeronima</dc:creator>
<dc:creator>Esteva, Magdalena</dc:creator>
<dc:creator>Morillo, Marta G</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Este estudio pretende estimar la seroprevalencia de la infección por Tripanosoma cruzi en sujetos bolivianos. Métodos: Estudio descriptivo transversal en Mallorca (España), en el cual sujetos bolivianos mayores de 18 años, asignados a médicos de familia de dos centros de salud, fueron seleccionados aleatoriamente de la base de Tarjeta Sanitaria Individual. Se citaron en el centro de salud para prueba serológica y entrevista. Se confirma como caso dos pruebas de ELISA positivas. Los resultados positivos o dudosos se enviaron al Centro Nacional de Microbiología para su confirmación. Resultados: Se incluyeron 251 sujetos (tasa de respuesta 36,3%). La seroprevalencia fue del 19,1% (intervalo de confianza del 95%: 14,06-24,19). La seroprevalencia fue mayor en quienes vivían en provincias endémicas, áreas rurales, casas de adobe o cuya madre o algún familiar había sufrido la infección. Conclusión: Este trabajo evidencia una alta prevalencia en personas bolivianas residentes que se asocia con los factores de riesgo ya establecidos (AU)</dc:description>
<dc:source>Gac Sanit;29(4): 288-291, jul.-ago. 2015. tab</dc:source>
<dc:identifier>ibc-140478</dc:identifier>
<dc:title xml:lang="es">Prevalencia de la enfermedad de Chagas en población boliviana de Mallorca (España)</dc:title>
<dc:subject>^d30425^s22069</dc:subject>
<dc:subject>^d52950</dc:subject>
<dc:subject>^d30425^s22012</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d11756</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24874</dc:subject>
<dc:subject>^d22443</dc:subject>
<dc:subject>^d1863^s22080</dc:subject>
<dc:subject>^d13411^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d28596</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d14752^s22052</dc:subject>
<dc:subject>^d28441^s22066</dc:subject>
<dc:subject>^d30425^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>201508</dc:date>
</metadata>
</record>
</ibecs-document>
